Today’s Top early Lunchtime Stocks: XERI, DGLY, QNRX, IBG, CNTM, and SBFM

April 2, 2025

DENVER, Colo., Apr 02, 2025 (247marketnews.com)- Xeriant (OTCQB:XERI) named Mark Sternberg, a nanomaterial maestro, to its Board of Directors. Sternberg’s arrival turbocharges Xeriant’s push to commercialize NEXBOARD™, its eco-friendly nanocomposite panel, at a moment when the company’s hitting peak stride.

Sternberg carved a legacy in nanotechnology, steering product development, manufacturing, and sales, over his 30-year career. As CEO of Moyco Precision Abrasives, he pioneered nanomaterial coatings and submicron abrasives, clinching a sale to Saint-Gobain, a $50 billion titan in industrial materials. Post-deal, he ran sales for Saint-Gobain’s $2 billion Abrasives division.

The move follows NEXBOARD building panel’s, forged from recycled plastic and fiber waste to outmuscle drywall and plywood, recent in-house 15 minutes of flame resistance test.

Digital Ally (NASDAQ:DGLY) is today’s most active stock, based on trading volume, and has an interesting gap from 11-cents to 15-cents.

Quoin Pharmaceuticals (NASDAQ:QNRX) reported stunning results from its ongoing pediatric Netherton Syndrome (NS) study. Six weeks into whole-body treatment with QRX003, a topical lotion targeting this rare skin disorder, the first young patient’s skin is nearly healed; a visual stunner that’s holding strong with daily dosing. This could be a lifeline for kids battling a disease with no cure or approved fix.

Beyond the durable healing, the patient’s ditched a cocktail of meds—antibiotics, antivirals, antihistamines, glucocorticoids—once staples for her fragile skin. Her pruritus (itch) Almost gone, delivering zero nightly sleep disruptions; a first in her life, no sedatives needed. There were no adverse events after six weeks of QRX003 use.

Regulators just greenlit testing on a second pediatric patient, doubling down on this estimated $1 billion rare disease market.

Innovation Beverage (NASDAQ:IBG) is currently trading at more than triple yesterday’s closing price and, more importantly, has cleared November’s price levels.

ConnectM Techn (NASDAQ:CNTM) reported receiving a non-binding offer to acquire all remaining outstanding CNTM shares for $1.60 per share in cash from its three largest institutional investors—SriSid LLC, Arumilli LLC, and Win-Light Global Co. Ltd.—and transition ConnectM into a privately held entity.

Sunshine Biopharma (NASDAQ:SBFM) is trading higher after publishing its 2024 financial results.

Please go to https://247marketnews.com/disclaimer/ or Xeriant lander for disclaimer information

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XERI, DGLY, QNRX, IBG, CNTM, SBFM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.